 Parent Directory | | |
 226.pdf | 2025-06-23 11:20 | 997k |
| 236.pdf | 2025-06-22 19:39 | 3947k |
| 255.pdf | 2025-06-22 19:47 | 1837k |
| 258.pdf | 2025-06-22 19:50 | 1578k |
| 271.pdf | 2025-06-22 19:52 | 2718k |
| 320.pdf | 2025-06-22 19:59 | 1067k |
| 324.pdf | 2025-06-22 23:50 | 751k |
| 367.pdf | 2025-06-22 20:26 | 2242k |
| Assessing the efficacy and tolerability of PET-guided BrECADD.pdf | 2025-06-23 11:22 | 1418k |
| cancers-13-02607.pdf | 2025-06-19 19:10 | 997k |
| nihms194857.pdf | 2025-06-23 09:56 | 1438k |
| Overall Survival with Brentuximab Vedotin.pdf | 2025-06-23 11:18 | 680k |
| PMC10318784.pdf | 2025-06-19 18:19 | 2384k |
| PMC10725609.pdf | 2025-06-22 23:54 | 7016k |
| PMC11963943.pdf | 2025-06-23 00:12 | 1277k |
| PMC8263883 (1).pdf | 2025-06-19 16:27 | 391k |
| PMC8263883.pdf | 2025-06-19 18:24 | 391k |
| PMC9078015.pdf | 2025-06-22 14:07 | 1053k |
| Seven-year overall survival analysis from ECHELON-1 study.pdf | 2025-06-23 11:22 | 57k |